首页>
外国专利>
AGENT FOR TREATMENT OF EXCESSIVE LIPID PEROXIDE IN SERUM
AGENT FOR TREATMENT OF EXCESSIVE LIPID PEROXIDE IN SERUM
展开▼
机译:治疗血清脂质过氧化物过多的药物
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE:To provide the titled remedy containing a specific carboxylic acid, its salt, its lower alkyl ester or its lactone, as an active component. CONSTITUTION:The objective agent is obtained by using the carboxylic acid of formula I (R1 is H or methyl) or formula II (R2 is H or methyl; R3 is OH or methoxy), its salt, its lower alkyl ester or its lactone, as an active component. The compound of formula I or formula II can be prepared by the microbial enzymatic hydroxidation of MB-530B or ML-236B (Japanese Patent Laid-open No. 56-110618) or their derivatives. Dose: 0.05-25mg/kg daily for M-4 compound, 0.1-50mg/kg daily for M-4' compound, iso-M-4 compound, etc., 0.05-25mg/kg daily for 3-hydroxy-MB-530B compound, etc., and 0.05-50mg/kg daily for 6- methoxy-iso-ML-236B compound.
展开▼
机译:目的:提供包含特定羧酸,其盐,其低级烷基酯或内酯作为活性成分的标题药物。组成:所述目标剂是通过使用式I的羧酸(R 1为H或甲基)或式II的羧酸(R 2为H或甲基; R 3为OH或甲氧基)得到的,其盐,其低级烷基酯或其内酯作为活性成分。式I或式II化合物可以通过MB-530B或ML-236B(日本特开56-110618号)或其衍生物的微生物酶促水氧化来制备。剂量:M-4化合物每天0.05-25mg / kg,M-4'化合物,iso-M-4化合物每天0.1-50mg / kg,3-羟基-MB-每天0.05-25mg / kg 530B化合物等,6-甲氧基-异-ML-236B化合物则为每日0.05-50mg / kg。
展开▼